European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia
Vaccination against SARS CoV-2 has made a tremendous difference and impact on the course of the SARS CoV-2 pandemic. This is indisputable. Vaccination against SARS...